LifeMD Names Experienced Pharma Executive Alexander Mironov as President
Retrieved on:
Friday, June 11, 2021
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion
Key Points:
- A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the Company) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced it has named Alexander Mironov as President of LifeMD. - Prior to Covis, Mr. Mironov held similar roles focusing on a buy and build strategy at Alvogen, Pernix Pharma, Esprit Pharma, EKR Therapeutics, and Valera Pharma.
- Mr. Mironov received options to purchase an aggregate of 200,000 shares of LifeMD, Inc. common stock.
- All forward-looking statements attributable to LifeMD, Inc., or a person acting on its behalf, are expressly qualified in their entirety by this cautionary language.